Dihydrotetrabenazine (DTBZ). We included eight patients diagnosed with PD (2f, 6m, 43-74y, mean 56y) and 4 healthy voluntary male controls (30-72y, mean 53.8y). All patients ... performed with GraphPad Prism 5. Results…
disease (PD). Methods: Fifteen PD patients in stage 1 of Hoehn and Yahr classification, 15 patients in stages 2 and 3, and 20 healthy matched control individuals, were extensively exposed ... However, as expected, this…
morphometry (VBM) was used to detect the differences between both sexes in PD and in healthy controls (HC). Also, a Pearson correlation coefficient was used to correlate depression values
cells were divided into 5 groups: control, shVect (transfected with p-super-EGFP-1 plasmid), pshMACC1 (transfected with psuper-EGFP-shMACC1 plasmid), PD (pretreated with 20 μM PD98059), and combined ... groups…
search for connection to disturbed iron homeostasis. 23 patients with AD, 17 cases with PD and 13 with ALS were included, 24 males (45.3%). They were clinically and neurologically reviewed ... PD: 49.8Ã?±5.1 Ã?µg/L…
labeling (ASL) perfusion magnetic resonance imaging approach. Twenty-three PD patients with mild-to-moderate stage disease and 29 normal control subjects underwent ASL MRI. Regional mean CBF values ... compared between…
patients was 55. The mean FA values of substantia nigra regions of PD patients when compared to controls, was lower but statistically not significant (0.4256 vs 0.44801, p=0.076). None ... showed statistically…
substituted acetylene monomers in a living fashion to give polymers with controlled molecular weights, geometry and end structures. Pd catalysts bearing bulky phosphine ligands polymerize disubstituted acetylene monomers
motor functions in patients with PD.Methods: In this prospective, controlled, open-label study, 18 patients with PD and mild depression (10 ≤ HDRS≤ 23,) without dementia (25 ≤ MMSE) were treated with ... motor…
depletion of dopamine in the striatum. Current therapeutic interventions of PD are aimed at controlling the symptoms of the disorder, but fail to halt the underlying degenerative process. The goal ... find the…
Dihydroxyphenylalanine (L-DOPA) is the most frequently prescribed drug for controlling the symptoms of PD. However, the high levels of L-DOPA lead to cell death by generating reactive oxygen
ELISA methods. The results obtained from HD, AD and PD patients were compared to age and gender matched healthy controls. Statistical analysis of established results was performed using Pearsonâ ... patients compared…
subjects were randomly assigned into two groups of intervention and control. The intervention and control groups received either 480 mg/d resveratrol or placebo capsules (2 PCs) for four weeks ... Moreover, significant…
identify the variables predicting and driving death in PD. Newly diagnosed PD patients and healthy controls (NC) from a population-based study that underwent recurrent evaluations over a ten-year ... proportional…
phosphate dehydrogenase (G-6-PD), an enzyme expressed in most human tissues is important in the generation of reduced glutathione - a key product in the control of oxidative stress ... total of 422 individuals – both…
pandemic. Methods: 76 participants were subdivided into three groups: 30 healthy people (control group), 30 diagnosed with PD treated only with drugs (drug group), and 16 with PD treated with ... linear regression were…
chemical that sends messages to the part of the brain that controls movement and coordination. As PD progresses, the amount of dopamine produced in the brain decreases, leaving a person
chemical that sends messages to the part of the brain that controls movement and coordination. As PD progresses, the amount of dopamine produced in the brain decreases, leaving a person
Programmed cell death protein 1 (PD-1), an immune suppressant controls the effector activity of T lymphocytes through interaction with Programmed death-ligand 1 protein (PD-L1). The T cells
astrocytes and its role in the nigral iron accumulation in PD, thus providing insight into the control of astrocytes function to protect neurons as therapeutic strategies of PD
dynamics play crucial roles in aging and pathogenesis of neurodegenerative diseases such as Parkinson (PD), Alzheimer (AD), and Huntington disease (HD). Photobiomodulation (PBM) represents a very promising therapeutic…
multiple clinical trials, including two randomized, double blinded, sham surgery controlled clinical trials of bilateral tissue transplant in PD. However, despite this rich history, there is a dearth of data ... from…
multiple clinical trials, including two randomized, double blinded, sham surgery controlled clinical trials of bilateral tissue transplant in PD. However, despite this rich history, there is a dearth of data ... from…
MDSC survival and infiltration of programmed death receptor-1 (PD-1)-expressing CD8+ T cells compared to controls. IDO-/- MDSCs downregulated nutrient-sensing AMP-activated protein kinase (AMPK) activity
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.